Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 1.94 USD -1.52% Market Closed
Market Cap: 89m USD

Intrinsic Value

The intrinsic value of one ENTX stock under the Base Case scenario is 0.03 USD. Compared to the current market price of 1.94 USD, Entera Bio Ltd is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENTX Intrinsic Value
0.03 USD
Overvaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Entera Bio Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ENTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ENTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Entera Bio Ltd.

Explain Valuation
Compare ENTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ENTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Entera Bio Ltd

Current Assets 17m
Cash & Short-Term Investments 8.6m
Other Current Assets 8.4m
Non-Current Assets 400k
PP&E 308k
Other Non-Current Assets 92k
Current Liabilities 1.6m
Accounts Payable 216k
Accrued Liabilities 1.1m
Other Current Liabilities 266k
Non-Current Liabilities 602k
Other Non-Current Liabilities 602k
Efficiency

Free Cash Flow Analysis
Entera Bio Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Entera Bio Ltd

Revenue
124k USD
Operating Expenses
-10.9m USD
Operating Income
-10.8m USD
Other Expenses
43k USD
Net Income
-10.8m USD
Fundamental Scores

ENTX Profitability Score
Profitability Due Diligence

Entera Bio Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

18/100
Profitability
Score

Entera Bio Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

ENTX Solvency Score
Solvency Due Diligence

Entera Bio Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Entera Bio Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENTX Price Targets Summary
Entera Bio Ltd

Wall Street analysts forecast ENTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENTX is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

Lowest
Price Target
10.1 USD
421% Upside
Average
Price Target
10.2 USD
426% Upside
Highest
Price Target
10.5 USD
441% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Entera Bio Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ENTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ENTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ENTX stock?

The intrinsic value of one ENTX stock under the Base Case scenario is 0.03 USD.

Is ENTX stock undervalued or overvalued?

Compared to the current market price of 1.94 USD, Entera Bio Ltd is Overvalued by 98%.

Back to Top